Physician profile
Peter J Adamson
NPI 1043669336
$20,563.41
in general payments reported to CMS, 2019-2025
21 companies · $1,525 in 2025
The $1,525 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $339 · 2020: $2,283 · 2021: $7,427 · 2022: $7,478 · 2023: $1,253 · 2024: $259 · 2025: $1,525.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,926 · Travel and Lodging: $1,111.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,926.22 |
| Travel and Lodging | $1,110.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Conetic Solutions, INC. | $5,479.46 | 2022-2025 | |
| Stryker Corporation | $4,818.82 | 2019-2025 | Mako, Aequalis, Alphavent |
| Titan Surgical Group, LLC | $3,618.83 | 2021-2022 | |
| Arthrex, INC. | $3,066.36 | 2022-2025 | |
| Medical Device Business Services, INC. | $2,674.91 | 2021 | |
| Vericel Corporation | $203.93 | 2022-2025 | Maci |
| Depuy Synthes Sales INC. | $148.61 | 2021-2025 | Na |
| Paragon 28, INC. | $131.12 | 2021 | |
| Smith+Nephew, INC. | $95.47 | 2025 | |
| Axogen | $76.48 | 2019-2020 | |
| Bioventus LLC | $42.54 | 2019-2021 | |
| Heraeus Medical, LLC. | $31.27 | 2019 | |
| Zimmer Biomet Holdings, INC. | $22.70 | 2019 | |
| Exactech, INC. | $22.67 | 2020 | |
| Ferring Pharmaceuticals INC. | $21.30 | 2024 | Euflexxa |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $20.61 | 2025 | |
| Lilly USA, LLC | $19.39 | 2025 | Mounjaro, Zepbound |
| Vertex Pharmaceuticals Incorporated | $19.27 | 2025 | |
| Pacira Pharmaceuticals Incorporated | $18.42 | 2025 | Zilretta |
| Teva Pharmaceuticals USA, INC. | $17.06 | 2025 | Austedo Xr |
| Medtronic, INC. | $14.19 | 2024 | Intellis Adaptivestim |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Peter Adamson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.